Swissmedic has accepted the new oral edarvarone formulation for the treatment of ALS

25 April 2022 - Mitsubishi Tanabe Pharma announced that Swissmedic has accepted the filing for an investigational oral suspension formalation ...

Read more →

Swissmedic grants conditional marketing authorisation for Novavax COVID-19 vaccine

13 April 2022 - Nuvaxovid is the first protein-based COVID-19 vaccine authorised for use in Switzerland. ...

Read more →

Switzerland approves its first protein-based Covid vaccine

15 April 2022 - Swissmedic announced its approval on Wednesday making Nuvaxovid the first protein-based vaccine to be licensed in Switzerland.  ...

Read more →

Despite competition, U.S. cancer drug prices rose even as they fell in Germany and Switzerland

24 March 2022 - Even as prices rose substantially in the U.S. over a recent 12 year period, a new ...

Read more →

MorphoSys and Incyte announce Swissmedic temporary approval of Minjuvi (tafasitamab) in combination with lenalidomide for the treatment of adults with r/r DLBCL

22 March 2022 - Minjuvi is a new therapeutic option for eligible DLBCL patients in Switzerland addressing an urgent unmet medical ...

Read more →

BeiGene announces approval for Brukinsa (zanubrutinib) by Swissmedic for treatment of adult patients with Waldenström’s macroglobulinaemia

17 February 2022 - With this approval, Brukinsa is now approved in 44 markets as BeiGene continues to advance its global ...

Read more →

Novavax files for conditional marketing authorisation of COVID-19 Vaccine in Switzerland

14 February 2022 - Novavax today announced its submission to Swissmedic, the Swiss Agency for Therapeutic Products, for conditional marketing authorisation ...

Read more →

Swissmedic grants temporary authorisation to Xevudy for COVID-19 patients

14 January 2022 - Corona medication Xevudy from GSK (sotrovimab) granted temporary authorisation in Switzerland ...

Read more →

Celltrion wins conditional nod for Regkirona in Switzerland

14 January 2022 - Celltrion said that Swiss Medic, Switzerland’s drug administration, has temporary authorisation for Regkirona (regdanvimab). ...

Read more →

Swiss regulator approves Roche-Regeneron COVID-19 drug

27 December 2021 - The Swiss medicines agency, Swissmedic, has given the green light to the monoclonal antibody cocktail Ronapreve developed ...

Read more →

Janssen COVID-19 booster shot approved in Switzerland

28 December 2021 - Medicines regulator Swissmedic has approved the booster of the single-dose vaccine from Johnson & Johnson. ...

Read more →

Pfizer/BioNTech vaccine approved for children by Swiss regulator

10 December 2021 - The Swiss medical regulator has approved the use of Pfizer/BioNTech’s Covid-19 vaccine for children aged five to ...

Read more →

Swiss regulator approves Pfizer/BioNTech booster for 16 and up

23 November 2021 - Swissmedic has approved the extension of COVID-19 boosters for the Pfizer/BioNTech vaccine to all people aged 16 ...

Read more →

EffRx obtains Swiss marketing authorization for Bronchitol in cystic fibrosis

4 November 2021 - EffRx Pharmaceuticals today announced that Swissmedic has approved Bronchitol (inhaled mannitol) for the treatment of cystic fibrosis ...

Read more →

AstraZeneca pulls request for Swiss approval of COVID shot

5 November 2021 - AstraZeneca says it is withdrawing its application for approval of its COVID-19 vaccine in Switzerland because the ...

Read more →